Patent · US Active

Inhibitor compounds of phosphodiesterase type 10A

US9856220B2 · kind B2 · utility

1Cited by

0References

26Claims

0Family size

Assignees

Abb Vie Deutschland Gmbh & Co. KG · DE
Abb Vie Inc. · US

Inventors

Hervé Geneste · Schifferstadt, DE
Michael Ochse · Wiesbaden, DE
Karla Drescher · Ludwigshafen, DE
Jurgen Dinges · Wadsworth, US
Clarissa Jakob · North Chicago, US

Key dates

Filing date	Jul 11, 2016
Grant date	Jan 2, 2018
Priority date	—
Expiry date	Jul 11, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds which are inhibitors of phosphodiesterase type 10A and to their use for the manufacture of a medicament and which thus are suitable for treating or controlling of medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.